Uliassi, E.; Bolognesi, M. L.; Milelli, A., Targeting Tau Protein with Proximity Inducing Modulators: A New Frontier to Combat Tauopathies, «ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE», 2025, 8, pp. 654 - 672 [articolo]
Lima, Clara M; Uliassi, Elisa; Thoré, Eli S J; Bertram, Michael G; Cardoso, Luis; Cordeiro da Silva, Anabela; Costi, Maria Paola; de Koning, Harry P, Environmental impacts of drugs against parasitic vector-borne diseases and the need to integrate sustainability into their development and use, «OPEN RESEARCH EUROPE», 2024, 4, pp. 1 - 23 [articolo]
Exertier, Cécile; Salerno, Alessandra; Antonelli, Lorenzo; Fiorillo, Annarita; Ocello, Riccardo; Seghetti, Francesca; Caciolla, Jessica; Uliassi, Elisa; Masetti, Matteo; Fiorentino, Eleonora; Orsini, Stefania; Di Muccio, Trentina; Ilari, Andrea; Bolognesi, Maria Laura, Fragment Merging, Growing, and Linking Identify New Trypanothione Reductase Inhibitors for Leishmaniasis, «JOURNAL OF MEDICINAL CHEMISTRY», 2024, 67, pp. 402 - 419 [articolo]Open Access
Martinengo, Bianca; Diamanti, Eleonora; Uliassi, Elisa; Bolognesi, Maria Laura, Harnessing the 12 Green Chemistry Principles for Sustainable Antiparasitic Drugs: Toward the One Health Approach, «ACS INFECTIOUS DISEASES», 2024, 10, pp. 1856 - 1870 [articolo]Open Access
Guardigni M.; Greco G.; Poeta E.; Santini A.; Tassinari E.; Bergamini C.; Zalambani C.; De Simone A.; Andrisano V.; Uliassi E.; Monti B.; Bolognesi M.L.; Fimognari C.; Milelli A., Integrating a quinone substructure into histone deacetylase inhibitors to cope with Alzheimer's disease and cancer, «RSC MEDICINAL CHEMISTRY», 2024, 15, pp. 2045 - 2062 [articolo]Open Access
Lopes, Flávia Barrio; Fernandes, João Paulo S; Uliassi, Elisa, Tackling Neuroinflammation in Cognitive Disorders with Single-targeted and Multi-targeted Histamine H3 Receptor Modulators, «CURRENT TOPICS IN MEDICINAL CHEMISTRY», 2024, 24, pp. 2421 - 2430 [articolo]
Albertini, Claudia; Petralla, Sabrina; Massenzio, Francesca; Monti, Barbara; Rizzardi, Nicola; Bergamini, Christian; Uliassi, Elisa; Borges, Fernanda; Chavarria, Daniel; Fricker, Gert; Goettert, Marcia; Kronenberger, Thales; Gehringer, Matthias; Laufer, Stefan; Bolognesi, Maria L, Targeting Lewy body dementia with neflamapimod-rasagiline hybrids, «ARCHIV DER PHARMAZIE», 2024, 357, Article number: 2300525, pp. 1 - 11 [articolo]
Pasieka, Anna; Diamanti, Eleonora; Uliassi, Elisa; Laura Bolognesi, Maria, Click Chemistry and Targeted Degradation: A Winning Combination for Medicinal Chemists?, «CHEMMEDCHEM», 2023, 18, Article number: e202300422, pp. 1 - 17 [articolo]Open Access
Guardigni M.; Pruccoli L.; Santini A.; Simone A.D.; Bersani M.; Spyrakis F.; Frabetti F.; Uliassi E.; Andrisano V.; Pagliarani B.; Fernández-Gómez P.; Palomo V.; Bolognesi M.L.; Tarozzi A.; Milelli A., PROTAC-Induced Glycogen Synthase Kinase 3β Degradation as a Potential Therapeutic Strategy for Alzheimer’s Disease, «ACS CHEMICAL NEUROSCIENCE», 2023, 14, pp. 1963 - 1970 [articolo]Open Access
Uliassi, E; Bergamini, C; Rizzardi, N; Naldi, M; Cores, A; Bartolini, M; Menéndez, JC; Bolognesi, ML, Quinolinetrione-tacrine hybrids as multi-target-directed ligands against Alzheimer's disease, «BIOORGANIC & MEDICINAL CHEMISTRY», 2023, 91, Article number: 117419, pp. 1 - 9 [articolo]Open Access
Rocío Marisol Espinoza Chávez; Salerno A.; Liuzzi A.; Ilari A.; Milelli A.; Uliassi E.; Bolognesi M.L., Targeted Protein Degradation for Infectious Diseases: from Basic Biology to Drug Discovery, «ACS BIO & MED CHEM AU», 2023, 3, pp. 32 - 45 [articolo]Open Access
Salerno, Alessandra; Seghetti, Francesca; Caciolla, Jessica; Uliassi, Elisa; Testi, Eleonora; Guardigni, Melissa; Roberti, Marinella; Milelli, Andrea; Bolognesi, Maria Laura, Enriching Proteolysis Targeting Chimeras with a Second Modality: When Two Are Better Than One, «JOURNAL OF MEDICINAL CHEMISTRY», 2022, 65, pp. 9507 - 9530 [articolo]Open Access
Lauriola A.; Uliassi E.; Santucci M.; Bolognesi M.L.; Mor M.; Scalvini L.; Elisi G.M.; Gozzi G.; Tagliazucchi L.; Marverti G.; Ferrari S.; Losi L.; D'Arca D.; Costi M.P., Identification of a Quinone Derivative as a YAP/TEAD Activity Modulator from a Repurposing Library, «PHARMACEUTICS», 2022, 14, Article number: 391, pp. 1 - 22 [articolo]Open Access
Albertini, C; Salerno, A; Atzenti, S; Uliassi, E; Massenzio, F; Maruca, A; Rocca, R; Mecava, M; Silva, FSG; Mena, D; Valente, P; Duarte, AI; Chavarria, D; Bissaro, M; Moro, S; Federico, S; Spalluto, G; Soukup, O; Borges, F; Alcaro, S; Monti, B; Oliveira, PJ; Menendez, JC; Bolognesi, ML, Riluzole-Rasagiline Hybrids: Toward the Development of Multi-Target-Directed Ligands for Amyotrophic Lateral Sclerosis, «ACS CHEMICAL NEUROSCIENCE», 2022, 13, pp. 2252 - 2260 [articolo]Open Access
Bianco M.D.C.A.D.; Inacio Leite D.; Silva Castelo Branco F.; Boechat N.; Uliassi E.; Bolognesi M.L.; Bastos M.M., The Use of Zidovudine Pharmacophore in Multi-Target-Directed Ligands for AIDS Therapy, «MOLECULES», 2022, 27, Article number: 8502, pp. 8502 - 8523 [articolo]Open Access
